Relationship between NF-κB1 and NF-κBIA genetic polymorphisms and Crimean-Congo hemorrhagic fever

Scandinavian Journal of Infectious Diseases

Volumn 44, Issue 2, 2012, Pages 138-143

  Arslan, Serdal ^a   Engin, Aynur ^a  

^a CUMHURIYET UNIVERSITY   (Turkey)

Author keywords

Crimean Congo hemorrhagic fever; Genetic polymorphism; NF B; NF BIA

Indexed keywords

I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; CRIMEAN CONGO HEMORRHAGIC FEVER; DISEASE COURSE; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREDICTOR VARIABLE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; ALLELES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEMORRHAGIC FEVER, CRIMEAN; HUMANS; MALE; MIDDLE AGED; NF-KAPPA B; POLYMORPHISM, GENETIC;

EID: 84856083727     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2011.623313     Document Type: Article

References (31)

1. Ergonul O. Crimean-Congo haemorrhagic fever. Lancet Infect Dis 2006;6:203-14.
2. Swanepoel R, Gill DE, Shepherd AJ, Leman PA, Mynhardt JH, Harvey S. The clinical pathology of Crimean-Congo hemorrhagic fever. Rev Infect Dis 1989;11(Suppl 4):S794 - 800.
3. Kraus AA, Mirazimi A. Molecular biology and pathogenesis of Crimean - Congo hemorrhagic fever virus. Future Virol 2010;5:469-79.
4. Pahl HL. Activators and target genes of Rel/NF-κ B transcription factors. Oncogene 1999;18:6853-66.
5. Siebenlist U, Franzoso G, Brown K. Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol 1994;10:405-55.
6. Heron E, Deloukas P, Van Loon AP. The complete exon- i ntron structure of the 150 kb human gene NFKB1, which encodes p105 and p50 proteins of transcription factors NF kappa B and I-kappa B gamma: implications for NF-kappa B-mediated signal transduction. Genomics 1995;30:493-507.
7. Karban AS, Okazaki T, Panhuysen CI, Gallegos T, Potter JJ, Bailey-Wilson JE, et al. Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Hum Mol Genet 2004;3:35-45. (Pubitemid 38072133)
8. Le Beau MM, Ito C, Cogswell P, Espinosa R, Fernald AA, Baldwin AS. Chromosomal localization of the genes encoding the p50/p105 subunits of NF-kappa B (NFKB2) and the NF- k B1 and NF- k BIA polymorphisms in CCHF 143 I kappa B/MAD-3 (NFKBI) inhibitor of NF-kappa B to 4q24 and 14q13, respectively. Genomics 1992;14:529-31.
9. Chiao PJ, Miyamoto S, Verma IM. Autoregulation of I? Ba activity. Proc Natl Acad Sci U S A 1994;91:28-32.
10. Hiscott J, Kwon H, Genin P. Hostile takeovers: viral appropriation of the NF- ? B pathway. J Clin Invest 2001;107: 143-151. (Pubitemid 32096827)
11. Saksida A, Duh D, Wraber B, Dedushaj I, Ahmeti S, Zupanc TA. Interacting roles of immune mechanisms and viral load in the pathogenesis of Crimean-Congo hemorrhagic fever. Clin Vaccine Immunol 2010;17:1086-93.
12. Bodur H, Akinci E, Onguru P, Uyar Y, Basturk B, G öz e MG. Evidence of vascular endothelial damage in Crimean-Congo hemorrhagic fever. Int J Infect Dis 2010;14:704-7.
13. Connolly-Andersen AM, Moll G, Andersson C, Akerströ m S, Karlberg H, Douagi I, et al. Crimean-Congo hemorrhagic fever virus activates endothelial cells. J Virol 2011;85:7766-74.
14. Papa A, Bino S, Velo E, Harxhi A, Kota M, Antoniadis A. Cytokine levels in Crimean-Congo hemorrhagic fever. J Clin Virol 2006;36:272-6. (Pubitemid 44066895)
15. Ergonul O, Tuncbilek S, Baykam N, Celikbas A, Dokuzoguz B. Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha in patients with Crimean- Congo hemorrhagic fever. J Infect Dis 2006;193:941-4.
16. Sun XF, Zhang H. NFKB and NFKBI polymorphisms inrelation to susceptibility of tumour and other diseases. Histol Histopathol 2007;22:1387-98. (Pubitemid 47470331)
17. Zhang GL, Zou YF, Feng XL. Association of the NFKBIA gene polymorphisms with susceptibility to autoimmune and infl amatory diseases: a meta-analysis. Infl amm Res 2010;60:11-8.
18. Tuncay S S? , Okyay P, Bardakci F. Identifi cation of NF- ? B1 and NF- ? BIA polymorphisms using PCR - RFLP assay in a Turkish population. Biochem Genet 2010;48:104-12.
19. Y eh FC, Yang RC, Boyle T. POPGENE, version 1.31: Microsoft Window-based freeware for population genetic analysis. University of Alberta; 1999. Available at: http://www.ualberta. ca/fyer (accessed 2010).
20. Gunes T, Engin A, Poyraz O. Crimean-Congo hemorrhagic fever virus in high-risk population, Turkey. Emerg Infect Dis 2009;15:461-4.
21. Karin M, Lin A. NF- ? B at the crossroads of life and death. Nat Immunol 2002;3:221-7.
22. Li Q, Verma IM. NF-kappaB regulation in the immune system. Nat Rev Immunol 2002;2:725-34.
23. Orozco G, Sanchez E, Collado MD, Lopez-Nevot MA, Paco L, Garcia A, et al. Analysis of the functional NFKB1 promoter polymorphism in rheumatoid arthritis and systemic lupus erythematosus. Tissue Antigens 2005;65:183-6. (Pubitemid 40342450)
24. Kurylowicz A, Hiromatsu Y, Jurecka-Lubieniecka B, Kula D, Kowalska M, Ichimura M, et al. Association of NFKB1 - 94ins/del ATTG promoter polymorphism with susceptibility to and phenotype of Graves ' disease. Genes Immun 2007;8: 532-5.
25. Lin CH, Ou TT, Wu CC, Tsai WC, Liu HW, Yen JH. I? B a promoter polymorphisms in patients with rheumatoid arthritis. Int J Immunogenet 2007;34:51-4.
26. Engin A, Arslan S, K i zi lda ǧ S, Ö zt ü k H, Elald i N, D ök meta Ş ?I, et al. Toll-like receptor 8 and 9 polymorphisms in Crimean- Congo hemorrhagic fever. Microbes Infect 2010;12:1071-8.
27. Klein W, Tromm A, Folwaczny C, Hagedorn M, Duerig N, Epplen JT, et al. A polymorphism of the NFKBIA gene is associated with Crohn ' s disease patients lacking a predisposing allele of the CARD15 gene. Int J Colorectal Dis 2004; 19:153-6. (Pubitemid 38239837)
28. Curran JE, Weinstein SR, Griffi ths LR. Polymorphic variants of NFKB1 and its inhibitory protein NFKBIA, and their involvement in sporadic breast cancer. Cancer Lett 2002;188:103-7. (Pubitemid 35292335)
29. Romzova M, Hohenadel D, Kolostova K, Pinterova D, Fojtikova M, Ruzickova S, et al. NF κ B and its inhibitor I κ B in relation to type 2 diabetes and its microvascular and atherosclerotic complications. Hum Immunol 2006;67:706-13. (Pubitemid 44430108)
30. Gao J, Pfeifer D, He LJ, Qiao F, Zhang Z, Arbman G, et al. Association of NFKBIA polymorphism with colorectal cancer risk and prognosis in Swedish and Chinese population. Scand J Gastroenterol 2007;42:345-50.
31. Parker KM, Ma MH, Manyak S, Altamirano CV, Tang YM, Frantzen M, et al. Identifi cation of polymorphisms of the I κ B a gene associated with an increased risk of multiple myeloma. Cancer Genet Cytogenet 2002;137:43-8